Stay updated on Pembrolizumab for Genomic Instability Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.

Latest updates to the Pembrolizumab for Genomic Instability Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe page’s displayed revision/version number has been bumped from v3.5.2 to v3.5.3, reflecting a website release update rather than a change to the study content.SummaryDifference0.1%

- Check20 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedStudy status updated to Active, not recruiting and results posted with related documentation (Results First Submitted/Posted) and dates. ORR outcome measure details are added to the Results section.SummaryDifference4%

- Check49 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a minor front-end update with no visible changes to the study details or related content.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.4.3 was added, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check85 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2. Core study details, eligibility criteria, and contact information appear unchanged.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Genomic Instability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.